Ring Therapeutics Raises $117 Million in Series B Funding to Expand Novel Vector Platform
Ring's novel vector Anellogy™ platform harnesses unique properties of anelloviruses to create a pipeline of redosable vectors compatible...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page